NCT01499459

Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis

Efficacy of Exvivo Expanded Autologous Mesenchymal Stem Cell Transplantation Via Peripheral Vein in Patients With Liver Cirrhosis

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (estimated)
• Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study is aiming to investigate the efficacy of autologous mesenchymal stem cell (MSC) transplantation in 25 randomized patients with liver cirrhosis autologous mesenchymal stem cell will be derived from patients' bone marrows and will be infused via peripheral vein. Liver biopsies will be performed in every patient in the beginning and at 6th month.

Conditions

• Liver Cirrhosis

Interventions

Type	Name	Description
GENETIC	autologous mesenchymal stem cell transplantation	Every patient is given 1x106 MSCs per kg infused via peripheral vein.

Timeline

• Start date: 2008-06-01
• Primary completion: 2012-07-01
• Completion: 2012-08-01
• First posted: 2011-12-26
• Last updated: 2012-03-22

Locations

1 site across 1 country: Turkey (Türkiye)